Angiotensin II type 1 receptor interaction is an important regulator for the development of pancreatic fibrosis in mice

American Journal of Physiology - Gastrointestinal and Liver Physiology

Volumn 287, Issue 1 50-1, 2004, Pages

  Nagashio, Yoshikuni ^a   Asaumi, Hiroshi ^a   Watanabe, Shiro ^a   Nomiyama, Yoko ^a   Taguchi, Masashi ^a   Tashiro, Mitsuo ^a   Sugaya, Takeshi ^b   Otsuki, Makoto ^a  

^a UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

^b Discov and Pharmacol Res Labs   (Japan)

Author keywords

Pancreatic stellate cells; Renin angiotensin system; Transforming growth factor 1

Indexed keywords

ALPHA ACTIN; ALPHA SMOOTH MUSCLE ACTIN; AMYLASE; ANGIOTENSIN; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 1A RECEPTOR; CERULETIDE; HYDROXYPROLINE; MESSENGER RNA; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG;

AMYLASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL ACTIVATION; CELL PROLIFERATION; CONTROLLED STUDY; CYSTIC FIBROSIS; DISEASE MODEL; HISTOLOGY; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; MALE; MOUSE; NONHUMAN; PANCREAS INJURY; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; STELLATE CELL; WESTERN BLOTTING;

ANIMALS; CAERULEIN; FIBROSIS; HYDROXYPROLINE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PANCREAS; PANCREATIC DISEASES; PROTEIN ISOFORMS; RECEPTOR, ANGIOTENSIN, TYPE 1; RECURRENCE; RNA, MESSENGER; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1;

EID: 3042554688     PISSN: 01931857     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpgi.00005.2004     Document Type: Article

References (48)

1. Ammann RW and Muellhaupt B. Progression of alcoholic acute to chronic pancreatitis. Gut 35: 552-556, 1994.
2. Apte MV, Haber PS, Applegate TL, Norton ID, McCaughan GW, Korsten MA, Pirola RC, and Wilson JS. Periacinar stellate shaped cells in rat pancreas: identification, isolation, and culture. Gut 43: 128-133, 1998.
3. Apte MV, Haber PS, Darby SJ, Rodgers SC, McCaughan GW, Korsten MA, Pirola RC, and Wilson JS. Pancreatic stellate cells are activated by proinflammatory cytokines: implications for pancreatic fibrogenesis. Gut 44: 534-541, 1999.
4. Bachem MG, Schneider E, Gross H, Weidenbach H, Schmid RM, Menke A, Siech M, Beger H, Grunert A, and Adler G. Identification, culture, and characterization of pancreatic stellate cells in rats and humans. Gastroenterology 115: 421-432, 1998.
5. Bataller R, Gines P, Nicolas JM, Gorbig MN, Garcia-Ramallo E, Gasull X, Bosch J, Arroyo V, and Rodes J. Angiotensin II induces contraction and proliferation of human hepatic stellate cells. Gastroenterology 118: 1149-1156, 2000.
6. Bataller R, Sancho-Bru P, Gines P, Lora JM, Al-Garawi A, Sole M, Colmenero J, Nicolas JM, Jimenez W, Weich N, Gutierrez-Ramos JC, Arroyo V, and Rodes J. Activated human hepatic stellate cells express the renin-angiotensin system, and synthesize angiotensin II. Gastroenterology 125: 117-125, 2003.
7. Border WA and Noble NA. Interactions of transforming growth factor-β and angiotensin II in renal fibrosis. Hypertension 31: 181-188, 1998.
8. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254, 1976.
9. Campbell SE and Katwa LC. Angiotensin II stimulated expression of transforming growth factor-β1 in cardiac fibroblasts and myofibroblasts. J Mol Cell Cardiol 29: 1947-1958, 1997.
10. Ceska M, Birath K, and Brown B. A new and rapid method for the clinical determination of α-amylase activities in human serum and urine. Optimal conditions. Clin Chim Acta 26: 437-444, 1969.
11. Chan WP, Fung ML, Nobiling R, and Leung PS. Activation of local renin-angiotensin system by chronic hypoxia in rat pancreas. Mol Cell Endocrinol 160: 107-114, 2000.
12. Friedman SL. The cellular basis of hepatic fibrosis. Mechanisms and treatment strategies. N Engl J Med 328: 1828-1835, 1993.
13. Gibbons GH, Pratt RE, and Dzau VJ. Vascular smooth muscle cell hypertrophy vs. hyperplasia. Autocrine transforming growth factor-β1 expression determines growth response to angiotensin II. J Clin Invest 90: 456-461, 1992.
14. Haber PS, Keogh GW, Apte MV, Moran CS, Stewart NL, Crawford DH, Pirola RC, McCaughan GW, Ramm GA, and Wilson JS. Activation of pancreatic stellate cells in human and experimental pancreatic fibrosis. Am J Pathol 155: 1087-1095, 1999.
15. Harada K, Sugaya T, Murakami K, Yazaki Y, and Komuro I. Angiotensin II type 1A receptor knockout mice display less left ventricular remodeling and improved survival after myocardial infarction. Circulation 100: 2093-2099, 1999.
16. Hisada Y, Sugaya T, Yamanouchi M, Uchida H, Fujimura H, Sakurai H, Fukamizu A, and Murakami K. Angiotensin II plays a pathogenic role in immune-mediated renal injury in mice. J Clin Invest 103: 627-635, 1999.
17. Ishidoya S, Morrissey J, McCracken R, Reyes A, and Klahr S. Angiotensin II receptor antagonist ameliorates renal tubulointerstitial fibrosis caused by unilateral ureteral obstruction. Kidney Int 47: 1285-1294, 1995.
18. Kagami S, Border WA, Miller DE, and Noble NA. Angiotensin II stimulates extracellular matrix protein synthesis through induction of transforming growth factor-β expression in rat glomerular mesangial cells. J Clin Invest 93: 2431-2437, 1994.
19. 4. Biochem Biophys Res Commun 308: 177-183, 2003.
20. Kim S and Iwao H. Molecular and cellular mechanisms of angiotensin II-mediated cardiovascular and renal diseases. Pharmacol Rev 52: 11-34, 2000.
21. Kloppel G and Maillet B. The morphological basis for the evolution of acute pancreatitis into chronic pancreatitis. Virchows Arch A 420: 1-4, 1992.
22. Kuno A, Yamada T, Masuda K, Ogawa K, Sogawa M, Nakamura S, Nakazawa T, Ohara H, Nomura T, Joh T, Shirai T, and Itoh M. Angiotensin-converting enzyme inhibitor attenuates pancreatic inflammation and fibrosis in male Wistar Bonn/Kobori rats. Gastroenterology 124: 1010-1019, 2003.
23. Kurikawa N, Suga M, Kuroda S, Yamada K, and Ishikawa H. An angiotensin II type 1 receptor antagonist, olmesartan medoxomil, improves experimental liver fibrosis by suppression of proliferation and collagen synthesis in activated hepatic stellate cells. Br J Pharmacol 139: 1085-1094, 2003.
24. Leung PS, Chan HC, Fu LX, and Wong PY. Localization of angiotensin II receptor subtypes AT1 and AT2 in the pancreas of rodents. J Endocrinol 153: 269-274, 1997.
25. Leung PS, Chan WP, and Nobiling R. Regulated expression of pancreatic renin-angiotensin system in experimental pancreatitis. Mol Cell Endocrinol 166: 121-128, 2000.
26. Leung PS, Chan WP, Wong TP, and Sernia C. Expression and localization of the renin-angiotensin system in the rat pancreas. J Endocrinol 160: 13-19, 1999.
27. Llorens-Cortes C, Greenberg B, Huang H, and Corvol P. Tissular expression and regulation of type 1 angiotensin II receptor subtypes by quantitative reverse transcriptase-polymerase chain reaction analysis. Hypertension 24: 538-548, 1994.
28. Luttenberger T, Schmid-Kotsas A, Menke A, Siech M, Beger H, Adler G, Grunert A, and Bachem MG. Platelet-derived growth factors stimulate proliferation and extracellular matrix synthesis of pancreatic stellate cells: implications in pathogenesis of pancreas fibrosis. Lab Invest 80: 47-55, 2000.
29. Massague J. The transforming growth factor-β family. Annu Rev Cell Biol 6: 597-641, 1990.
30. Matsusaka T, Hymes J, and Ichikawa I. Angiotensin in progressive renal diseases: theory and practice. J Am Soc Nephrol 7: 2025-2043, 1996.
31. Mews P, Phillips P, Fahmy R, Korsten M, Pirola R, Wilson J, and Apte M. Pancreatic stellate cells respond to inflammatory cytokines: potential role in chronic pancreatitis. Gut 50: 535-541, 2002.
32. Mezzano SA, Ruiz-Ortega M, and Egido J. Angiotensin II and renal fibrosis. Hypertension 38: 635-638, 2001.
33. Neuschwander-Tetri BA, Bridle KR, Wells LD, Marcu M, and Ramm GA. Repetitive acute pancreatic injury in the mouse induces procollagen α1(I) expression colocalized to pancreatic stellate cells. Lab Invest 80: 143-150, 2000.
34. Niederau C, Ferrell LD, and Grendell JH. Caerulein-induced acute necrotizing pancreatitis in mice: protective effects of proglumide, benzotript, and secretin. Gastroenterology 88: 1192-1204, 1985.
35. Oparil S and Haber E. The renin-angiotensin system. N Engl J Med 291: 389-401, 1974.
36. Oparil S and Haber E. The renin-angiotensin system. N Engl J Med 291: 446-457, 1974.
37. Satoh M, Kashihara N, Yamasaki Y, Maruyama K, Okamoto K, Maeshima Y, Sugiyama H, Sugaya T, Murakami K, and Makino H. Renal interstitial fibrosis is reduced in angiotensin II type 1a receptor-deficient mice. J Am Soc Nephrol 12: 317-325, 2001.
38. Schieffer B, Wirger A, Meybrunn M, Seitz S, Holtz J, Riede UN, and Drexler H. Comparative effects of chronic angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor blockade on cardiac remodeling after myocardial infarction in the rat. Circulation 89: 2273-2282, 1994.
39. Schneider E, Schmid-Kotsas A, Zhao J, Weidenbach H, Schmid RM, Menke A, Adler G, Waltenberger J, Grunert A, and Bachem MG. Identification of mediators stimulating proliferation and matrix synthesis of rat pancreatic stellate cells. Am J Physiol Cell Physiol 281: C532-C543, 2001.
40. Sugaya T, Nishimatsu S, Tanimoto K, Takimoto E, Yamagishi T, Imamura K, Goto S, Imaizumi K, Hisada Y, Otsuka A, Uchida H, Sugiura M, Fukuta K, Fukamizu A, and Murakami K. Angiotensin II type 1a receptor-deficient mice with hypotension and hyperreninemia. J Biol Chem 270: 18719-18722, 1995.
41. Timmermans PB, Wong PC, Chiu AT, Herblin WF, Benfield P, Carini DJ, Lee RJ, Wexler RR, Saye JA, and Smith RD. Angiotensin II receptors and angiotensin II receptor antagonists. Pharmacol Rev 45: 205-251, 1993.
42. Tsang SW, Ip SP, and Leung PS. Prophylactic and therapeutic treatments with AT1 and AT2 receptor antagonists and their effects on changes in the severity of pancreatitis. Int J Biochem Cell Biol 36: 330-339, 2004.
43. Tsang SW, Ip SP, Wong TP, Che CT, and Leung PS. Differential effects of saralasin and ramiprilat, the inhibitors of renin-angiotensin system, on cerulein-induced acute pancreatitis. Regul Pept 28: 47-53. 2003.
44. Unger T. The role of the renin-angiotensin system in the development of cardiovascular disease. Am J Cardiol 89: 3A-9A, 2002.
45. Woessner JFJ. The determination of hydroxyproline in tissue and protein samples containing small amounts of the amino acid. Arch Biochem Biophys 93: 440-447, 1961.
46. Yamada T, Kuno A, Masuda K, Ogawa K, Sogawa M, Nakamura S, Ando T, Sano H, Nakazawa T, Ohara H, Nomura T, Joh T, and Itoh M. Candesartan, an angiotensin II receptor antagonist, suppresses pancreatic inflammation and fibrosis in rats. J Pharmacol Exp Ther 307: 17-23, 2003.
47. Yoshiji H, Kuriyama S, Yoshii J, Ikenaka Y, Noguchi R, Nakatani T, Tsujinoue H, and Fukui H. Angiotensin-II type 1 receptor interaction is a major regulator for liver fibrosis development in rats. Hepatology 34: 745-750, 2001.
48. Yoshikawa H, Kihara Y, Taguchi M, Yamaguchi T, Nakamura H, and Otsuki M. Role of TGF-β1 in the development of pancreatic fibrosis in Otsuka Long-Evans Tokushima Fatty rats. Am J Physiol Gastrointest Liver Physiol 282: G549-G558, 2002.